Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 4/20 | 0.64 |
| ▸ | GABBR1 | Q9UBS5 | 4/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.63 |
| ▸ | DRD3 | P35462 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | FNTA | P49354 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2226074 | 0.90 | L3MBTL1 (0.68) | KMT2AFFAR1L3MBTL1FNTAFNTB | |
| SCHEMBL4453571 | 0.85 | FFAR1 (0.78) | KMT2AGAAFFAR1L3MBTL1FNTA | |
| SCHEMBL5340895 | 0.82 | L3MBTL1 (0.59) | KMT2AFFAR1L3MBTL1FNTAFNTB | |
| SCHEMBL11079771 | 0.82 | ALDH1A1 (0.54) | CYP3A4CYP1A2CYP2D6CYP2C19TSHR | |
| SCHEMBL21631926 | 0.81 | GABBR2 (0.61) | GABBR2GABBR1KMT2ALMNACYP2C9 | |
| SCHEMBL13940816 | 0.81 | GABBR2 (0.70) | GABBR2GABBR1KMT2ALMNACYP2C9 | |
| SCHEMBL18386267 | 0.81 | GABBR2 (0.70) | GABBR2GABBR1KMT2ALMNACYP2C9 | |
| SCHEMBL6484578 | 0.80 | FFAR1 (0.66) | KMT2ALMNACYP2C9CYP3A4CYP1A2 | |
| SCHEMBL11023933 | 0.80 | FFAR1 (0.60) | KMT2AGAAFFAR1L3MBTL1FNTA | |
| SCHEMBL28854188 | 0.80 | FFAR1 (0.59) | KMT2AFFAR1L3MBTL1FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-219283790-U | Continuous and efficient drying device for o/p-toluenesulfonamide | 浙江嘉化新材料有限公司 | 2023-06-30 | — | — | CN | claimed |
| US-20250079447-A1 | NEGATIVE ELECTRODE ACTIVE MATERIAL AND NEGATIVE ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4465384-A1 | NEGATIVE ELECTRODE ACTIVE MATERIAL AND NEGATIVE ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-11-20 | — | — | EP | disclosed |
| CN-219283790-U | Continuous and efficient drying device for o/p-toluenesulfonamide | 浙江嘉化新材料有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-219283790-U | Continuous and efficient drying device for o/p-toluenesulfonamide | 浙江嘉化新材料有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-113226713-B | Additive manufacturing system, method and medium for producing three-dimensional objects | 惠普发展公司，有限责任合伙企业 | 2023-06-20 | — | — | CN | disclosed |
| CN-112442356-B | ABX 3 Preparation method of type stable perovskite quantum dot | 南京邮电大学 | 2022-10-14 | — | — | CN | disclosed |
| CN-110072904-B | Composition comprising fibrous material and thermoplastic binder | 汉高股份有限及两合公司 | 2022-05-24 | — | — | CN | disclosed |
| US-8569336-B2 | Compounds for the treatment of inflammatory disorders | TONG LING (US) | 2013-10-29 | — | — | US | disclosed |
| US-8569336-B2 | Compounds for the treatment of inflammatory disorders | TONG LING (US) | 2013-10-29 | — | — | US | disclosed |
| US-20120015926-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | TONG LING (US) | 2012-01-19 | — | — | US | disclosed |
| US-20120015926-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | TONG LING (US) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015926-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | TNF, ADAMTS1, ADAMTS7 | GABBR2 2870/4885GABBR1 3154/4885KMT2A 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.